Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | NAAA | Q02083 | 2/20 | 0.49 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 4/20 | 0.43 |
| ▸ | CES1 | P23141 | 4/20 | 0.43 |
| ▸ | SQOR | Q9Y6N5 | 2/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4090761 | 0.98 | NAAA (0.51) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| Ammonia Solution, Strong SCHEMBL28319392 | 0.98 | L3MBTL1 (0.48) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| SCHEMBL149820 | 0.98 | NAAA (0.51) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| SCHEMBL6687038 | 0.98 | NAAA (0.51) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| SCHEMBL7766948 | 0.98 | NAAA (0.51) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| SCHEMBL1892070 | 0.98 | NAAA (0.51) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| SCHEMBL6687882 | 0.98 | NAAA (0.51) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| SCHEMBL29067286 | 0.96 | NAAA (0.50) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| SCHEMBL12108939 | 0.94 | L3MBTL1 (0.42) | L3MBTL1NAAAFAAHPOLBKMT2A | |
| SCHEMBL29366012 | 0.89 | LMNA (0.40) | L3MBTL1NAAAFAAHPOLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116549713-B | Surgical patch with tissue adhesion and anti-adhesion functions and preparation method thereof | 浙江大学 | 2025-06-13 | — | — | CN | disclosed |
| CN-116549713-A | Surgical patch with tissue adhesion and anti-adhesion functions and preparation method thereof | 浙江大学 | 2023-08-08 | — | — | CN | disclosed |
| EP-2106812-B1 | Methods of Making and Using Surfactant Polymers | NANOMIMETICS INC (US) | 2016-01-13 | — | — | EP | disclosed |
| US-9125969-B2 | Methods of making and using surfactant polymers | NANOMIMETICS, INC. (US) | 2015-09-08 | — | — | US | disclosed |
| US-20120245288-A1 | METHODS OF MAKING AND USING SURFACTANT POLYMERS | NANOMIMETICS, INC. (US) | 2012-09-27 | — | — | US | disclosed |
| US-8163302-B2 | Methods of making and using surfactant polymers | NANOMIMETICS, INC. (US) | 2012-04-24 | — | — | US | disclosed |
| EP-2106812-A2 | Methods of Making and Using Surfactant Polymers | NanoMimetics, Inc. (US) | 2009-10-07 | — | — | EP | disclosed |
| EP-1086149-B1 | SURFACTANTS THAT MIMIC THE GLYCOCALYX | MARCHANT ROGER E (US) | 2009-07-29 | — | — | EP | disclosed |
| US-20080262614-A1 | METHODS OF MAKING AND USING SURFACTANT POLYMERS | NANOMIMETICS, INC. (US) | 2008-10-23 | — | — | US | disclosed |
| US-20080247988-A1 | METHODS OF MAKING AND USING SURFACTANT POLYMERS | MARCHANT, ROGER E. | 2008-10-09 | — | — | US | disclosed |
| US-7276474-B2 | Methods of making and using surfactant polymers | NANOMIMETICS, INC. (US) | 2007-10-02 | — | — | US | disclosed |
| US-20050008603-A1 | Methods of making and using surfactant polymers | NANOMIMETICS, INC. | 2005-01-13 | — | — | US | disclosed |
| US-6759388-B1 | COMBLIKE POLYMERS; INCREASING BLOOD BIOCOMPATIBILITY OF IMPLANTS; SUCH AS OLIGOSACCHARIDE OR OLIGOPEPTIDE SIDE CHAIN DERIVATIZED POLYVINYL AMIDE, POLYVINYL ALCOHOL OR POLYLYSINE | NANOMIMETICS, INC. | 2004-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008603-A1 | Methods of making and using surfactant polymers | MSR1, CD14, PLOD3 | L3MBTL1 1954/4885NAAA 1899/4885FAAH 2535/4885 |
| US-20080247988-A1 | METHODS OF MAKING AND USING SURFACTANT POLYMERS | MSR1, CD14, PLOD3 | L3MBTL1 1954/4885NAAA 1899/4885FAAH 2535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.